INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer

NEXT STORY
LipoMedix Appoints New Members to Board of Directors and Creates New Executive Committee
PREV STORY
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma

author_avatar
NASDAQ Market News

OV – Oncology Venture får godkännande att utöka den pågående fas 2-studien av LiPlaCis med prostatacancerpatienter

Hoersholm, Danmark, 4 oktober 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) ...

author_avatar
NASDAQ Market News

Anthera Announces Expansion of Screening in European Sites in Phase 3 RESULT Clinical Study of Sollpura

Study is being conducted in the US, Europe, and IsraelTop line data expected end ...

author_avatar
NASDAQ Market News